IRDVSNDRA• 3 Months (Normalized)
IRD vs NDRA (Opus Genetics Inc. vs ENDRA Life Sciences Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IRD Performance $6.04
+54.08%
Opus Genetics Inc.
Normalized Baseline0.00%
NDRA Performance $5.62
+15.88%
ENDRA Life Sciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin IRD LEADS
+38.2%
IRD outperforming by 38.20%
IRDNDRA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IRD NDRA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | IRD Price | IRD Gain (%) | NDRA Price | NDRA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $6.04 | +54.08% | $5.62 | +15.88% | +38.20% |
| Sep 10, 2026 | $6.07 | +54.85% | $5.79 | +19.28% | +35.57% |
| Sep 09, 2026 | $5.73 | +46.17% | $5.83 | +20.21% | +25.96% |
| Sep 08, 2026 | $4.34 | +10.71% | $5.91 | +21.75% | -11.04% |
| Sep 04, 2026 | $4.67 | +19.13% | $6.05 | +24.74% | -5.61% |
| Sep 03, 2026 | $4.60 | +17.35% | $5.68 | +17.11% | +0.24% |
| Sep 02, 2026 | $4.45 | +13.52% | $6.46 | +33.20% | -19.68% |
| Sep 01, 2026 | $3.83 | -2.30% | $5.27 | +8.66% | -10.96% |
| Aug 31, 2026 | $3.62 | -7.65% | $5.01 | +3.20% | -10.85% |
| Aug 28, 2026 | $3.69 | -5.87% | $5.01 | +3.20% | -9.07% |
| Aug 27, 2026 | $3.85 | -1.79% | $5.41 | +11.44% | -13.23% |
| Aug 26, 2026 | $3.80 | -3.06% | $5.44 | +12.16% | -15.22% |
| Aug 25, 2026 | $4.11 | +4.85% | $4.75 | -2.06% | +6.91% |
| Aug 24, 2026 | $4.03 | +2.81% | $4.56 | -5.98% | +8.79% |
| Aug 21, 2026 | $4.05 | +3.32% | $4.49 | -7.42% | +10.74% |
Page 1 of 5